Prospective evaluation of definitive chemoradiotherapy with volumetric modulated arc therapy in patients with muscle invasive carcinoma of urinary bladder

Autor: Madhup Rastogi, Ajeet K. Gandhi, Ramakant Tiwari, Sambit S. Nanda, Satyajeet Rath, Rohini Khurana, Rahat Hadi, Shantanu Sapru, Anoop Srivastava, Diwakar Dalela

Publikováno v: Contemporary Oncology, Vol 24, Iss 3, Pp 177-182 (2020)

Externí odkaz: https://doaj.org/article/427e66dc4bbc423f9f48f569bd5d9f1f

Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit.

Autor: Mishra BK; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Kapoor A; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Gupta A; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Sansar B; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Singh A; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Roy S; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Mandal T; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Srinivas S; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Das S; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Mishra A; Department of Head and Neck Surgery, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Mukherjee A; Department of Radiation Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Nanda S; Department of Radiation Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India., Sambasivaiah K; Department of Medical Oncology, Mahamana Pandit Madan Mohan Malviya Cancer Centre & Homi Bhabha Cancer Hospital, Tata Memorial Centre, Varanasi, 221005, India.

Publikováno v: Ecancermedicalscience [Ecancermedicalscience] 2022 Nov 02; Vol. 16, pp. 1460. Date of Electronic Publication: 2022 Nov 02 (Print Publication: 2022).

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus.

Autor: Odqvist L; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Jevnikar Z; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Riise R; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Öberg L; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Rhedin M; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Leonard D; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Yrlid L; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Jackson S; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Mattsson J; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Nanda S; MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK., Cohen P; MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK., Knebel A; MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK., Arthur S; Division of Immunology and Cell Signaling, School of Life Sciences, University of Dundee, Dundee, UK., Thörn K; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Svenungsson E; Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden., Jönsen A; Skåne University Hospital, Department of Clinical Science Lund, Rheumatology, Lund University, Lund, Sweden., Gunnarsson I; Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden., Tandre K; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Alexsson A; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Kastbom A; Department of Rheumatology and Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden., Rantapää-Dahlqvist S; Department of Public Health and Clinical Medicine/Rheumatology, Umeå Universitet Medicinska fakulteten, Umea, Sweden., Eloranta ML; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Syvänen AC; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Bengtsson A; Skåne University Hospital, Department of Clinical Science Lund, Rheumatology, Lund University, Lund, Sweden., Johansson P; Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Sandling JK; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Sjöwall C; Department of Rheumatology and Department of Clinical and Experimental Medicine, Linköping University, Linkoping, Sweden., Rönnblom L; Department of Medical Sciences, Science for Life Laboratories, Uppsala University, Uppsala, Sweden., Collins B; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden., Vaarala O; Research and Early Development, Respiratory, Inflammation and Autoimmune, BioPharmaceuticals R&D, AstraZeneca R&D Gothenburg, Mölndal, Sweden vaaralao@medimmune.com.; Respiratory, Inflammation and Autoimmunity Department, MedImmune LLC, Gaithersburg, Maryland, USA.

Publikováno v: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Oct; Vol. 78 (10), pp. 1363-1370. Date of Electronic Publication: 2019 Jul 12.

An important role for A20-binding inhibitor of nuclear factor-kB-1 (ABIN1) in inflammation-mediated endothelial dysfunction: an in vivo study in ABIN1 (D485N) mice.

Autor: Akbar N; Vascular and Inflammatory Diseases Research Unit, Medical Research Institute, Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. n.akbar@dundee.ac.uk., Nanda S; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, College of Life Sciences, University of Dundee, Dundee, UK. s.k.nanda@dundee.ac.uk., Belch J; Vascular and Inflammatory Diseases Research Unit, Medical Research Institute, Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. j.j.f.belch@dundee.ac.uk., Cohen P; MRC Protein Phosphorylation and Ubiquitylation Unit, Sir James Black Centre, College of Life Sciences, University of Dundee, Dundee, UK. p.cohen@dundee.ac.uk., Khan F; Vascular and Inflammatory Diseases Research Unit, Medical Research Institute, Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK. f.khan@dundee.ac.uk.

Publikováno v: Arthritis research & therapy [Arthritis Res Ther] 2015 Feb 04; Vol. 17, pp. 22. Date of Electronic Publication: 2015 Feb 04.

Molecular control of the NEMO family of ubiquitin-binding proteins.

Autor: Clark K; Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, Sir James Black Centre, University of Dundee, Dundee, DD1 5EH, Scotland, UK., Nanda S, Cohen P

Publikováno v: Nature reviews. Molecular cell biology [Nat Rev Mol Cell Biol] 2013 Oct; Vol. 14 (10), pp. 673-85. Date of Electronic Publication: 2013 Aug 29.